Moolmuang, B., & Ruchirawat, M. (2021). The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells. J Pharm Pharmacol, 73(1), 40-51. doi:10.1093/jpp/rgaa050

01 Mar 2021
0

Moolmuang, B., & Ruchirawat, M. (2021). The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells. J Pharm Pharmacol, 73(1), 40-51. doi:10.1093/jpp/rgaa050

Tags

Share this

Related Posts

Identifying important life stages for monitoring and assessing risks from exposures to environmental contaminants: Results of a World Health Organization review. Cohen Hubal, E. A., de Wet, T., Du Toit, L., Firestone, M. P., Ruchirawat, M., van Engelen, J., & Vickers, C. (2014). Regulatory Toxicology and Pharmacology, 69(1), 113-124.

Recent Posts